ORKA Sale Disclosure
Quinlan Paul T · SEC Form 4 · Filed Oct 20, 2026
Sale
Calculated transaction value
$38.06K
Quinlan Paul T General Counsel
ORKA
Oruka Therapeutics
ORKA
Transaction date
Oct 20, 2026
Public filing date
Oct 20, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$79.09
Oct 20, 2026
First close after public filing
$79.92
Oct 21, 2026
Return after filing · so far
+36.09%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 500 shares @ $76.12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000110
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$776.93K
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 20, 2026 | $323.04K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Oct 20, 2026 | $38.06K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 20, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 20, 2026 | $29.96K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 20, 2026 | $70.2K |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 20, 2026 | $77.2K |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 20, 2026 | $238.47K |